drugset / Trial / NCT07399951
Washington University WU 409: Immune Responses to Rabies Vaccine.
RandomizedSingle-groupOpen-labelBasic science
Summary
This study will evaluate the immune response to rabies vaccination persons 18 years and older. We will evaluate thirty healthy participants across three cohorts: 1) standard rabies pre-exposure prophylaxis regimen (two doses of Imovax® or RabAvert® seven days apart with no RIG); 2) rabies pre-exposure prophylaxis regimen + day 0 RIG (two doses of Imovax® or RabAvert® seven days apart, with RIG administered at day 0); 3) rabies pre-exposure prophylaxis regimen + day 28 RIG (two doses of Imovax® or RabAvert® seven days apart, with RIG administered at day 28).
Timeline
- Start
- 2023-10-19
- Primary completion
- 2025-06-24
- Completion
- 2025-10-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | HyperRAB | Unknown | — | — |
| Subject | Imovax | Vaccine | — | — |
| Subject | Rabies vaccine | Vaccine | — | — |
Indications
No indication recorded.